EpiStem Holdings (EHP)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

400.00p
   
  • Change Today:
    -2.50p
  • 52 Week High: 422.50
  • 52 Week Low: 352.50
  • Currency: UK Pounds
  • Shares Issued: 8.85m
  • Volume: 3,970
  • Market Cap: £35.40m
  • RiskGrade: 52
  • Beta: 0.05

Latest ShareCast News

Big things expected of EpiStem's Genedrive device

By John Harrington

Date: Tuesday 11 Oct 2011

Epistem, the biotechnology company specialising in diagnostic aids for the treatment of cancer and gastrointestinal diseases, continued on its steady growth path last year.

EHP ShareCast News

Epistem sees solid growth 29-Mar-2011 ShareCast
Maiden pre-tax profit for Epistem 05-Oct-2010 ShareCast
Small caps: Titon, Utd Drug, Vernalis... 29-Jul-2010 ShareCast
EpiStem breaks even as revenue soars 09-Mar-2010 ShareCast
Small caps round-up: Nautical Petroleum, ThirdFo... 09-Nov-2009 ShareCast

EHP Regulatory News

Director/PDMR Shareholding 02-May-2012 08:42 RNS
Director/PDMR Shareholding 03-Apr-2012 16:53 RNS
Additional Listing 27-Mar-2012 09:13 RNS
Half Yearly Report 14-Mar-2012 07:00 RNS
Epistem Announces a Three Year Collaboration wit... 13-Mar-2012 07:01 MW

EHP Newspaper Links

No recent information was found.

EHP Tips & Analysis

Broker lifts Northern Petroleum 05-Apr-2007 Times

EHP News Wires

No recent information was found.

Other EHP News


The company’s business model is b...

31-Jul-2009 Proactive Investors
Shares in biotechnology and research services co... 02-Mar-2009 Proactive Investors
Market round-up: Bailout rollercoaster 03-Oct-2008 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

EHP Market Data

Currency UK Pounds
Share Price 400.00p
Change Today -2.50p
% Change -0.62 %
52 Week High 422.50
52 Week Low 352.50
Volume 3,970
Shares Issued 8.85m
Market Cap £35.40m
Beta 0.05
RiskGrade 52

EHP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.59% below the market average93.59% below the market average93.59% below the market average93.59% below the market average93.59% below the market average
87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average
Price Trend
50.97% above the market average50.97% above the market average50.97% above the market average50.97% above the market average50.97% above the market average
17.86% above the sector average17.86% above the sector average17.86% above the sector average17.86% above the sector average17.86% above the sector average
Income Not Available
Growth
53.44% above the market average53.44% above the market average53.44% above the market average53.44% above the market average53.44% above the market average
2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EHP Dividends

No dividends found

Trades for 28-May-2012

Time Volume / Share Price
14:06 700 @ 395.00p
13:05 3,270 @ 380.00p

EHP Key Personnel

CEO Matthew Walls
Finance Director John Rylands

Top of Page